Mifepristone combined with ethacridine lactate for third-trimester stillbirth induction: a 5-year experience from Shanghai

OBJECTIVE: To review and analyze the efficacy and safety of mifepristone combined with ethacridine lactate for induction of stillbirth in the third trimester. METHODS: All patients with stillbirth in late pregnancy (≥ 28 weeks) in a university-affiliated maternity center from October 2016 to Septemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Rui-Hong, Li, Juan, Yao, Yong-Li, Huang, Run-Jie, Ma, Jue, Zhang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597990/
https://www.ncbi.nlm.nih.gov/pubmed/36289479
http://dx.doi.org/10.1186/s12884-022-05104-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597990/
https://www.ncbi.nlm.nih.gov/pubmed/36289479
http://dx.doi.org/10.1186/s12884-022-05104-0

Ejemplares similares